In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.
Saved in:
| Title: | In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody. |
|---|---|
| Authors: | Reid J; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK., Zamuner S; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK., Edwards K; Statistics, GlaxoSmithKline, Stevenage, UK., Rumley SA; Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, UK., Nevin K; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK., Feeney M; Biopharm Research, GlaxoSmithKline, Stevenage, UK., Zecchin C; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK., Fernando D; Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, UK., Wisniacki N; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2018 Oct; Vol. 84 (10), pp. 2280-2291. Date of Electronic Publication: 2018 Jul 12. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29900565 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reid+J%22">Reid J</searchLink>; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Zamuner+S%22">Zamuner S</searchLink>; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Edwards+K%22">Edwards K</searchLink>; Statistics, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Rumley+SA%22">Rumley SA</searchLink>; Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Nevin+K%22">Nevin K</searchLink>; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Feeney+M%22">Feeney M</searchLink>; Biopharm Research, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Zecchin+C%22">Zecchin C</searchLink>; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Fernando+D%22">Fernando D</searchLink>; Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Wisniacki+N%22">Wisniacki N</searchLink>; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2018 Oct; Vol. 84 (10), pp. 2280-2291. <i>Date of Electronic Publication: </i>2018 Jul 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29900565 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bcp.13669 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2280 Titles: – TitleFull: In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reid J – PersonEntity: Name: NameFull: Zamuner S – PersonEntity: Name: NameFull: Edwards K – PersonEntity: Name: NameFull: Rumley SA – PersonEntity: Name: NameFull: Nevin K – PersonEntity: Name: NameFull: Feeney M – PersonEntity: Name: NameFull: Zecchin C – PersonEntity: Name: NameFull: Fernando D – PersonEntity: Name: NameFull: Wisniacki N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2018 Oct Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1365-2125 Numbering: – Type: volume Value: 84 – Type: issue Value: 10 Titles: – TitleFull: British journal of clinical pharmacology Type: main |
| ResultId | 1 |